🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Siegfried Janz

Medical College of Wisconsin

ORCID: 0000-0002-2229-5511

Also affiliated with National Research Council Canada

EngineeringMedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Anaplastic, Plasmablastic, and Plasmacytic Plasmacytomas of Mice: Relationships to Human Plasma Cell Neoplasms and Late-Stage Differentiation of Normal B Cells

(2023)10.1158/0008-5472.c.6495266.v1
Top 100%
0DataRank
Top 100%0 citations

Jeff X. Zhou, Chang Hoon Lee, Zohreh Naghashfar, Shao Xiang, Alexander L. Kovalchuk +7 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth”.

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth

Nature Communications(2024)10.1038/s41467-024-44873-4
N/A
0.571DataRank · unranked
44 citations

Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu +18 more

WDR26 and MTF2 are therapeutic targets in multiple myeloma

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01217-9
N/A
0DataRank · unranked
14 citations

Yan Cheng, Jesse D. Riordan, Adam J. Dupuy, Wendy Dubois, Michael Pisano +6 more

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0016
N/A
0DataRank · unranked
7 citations

Fumou Sun, Yan Cheng, Brent Holmes, Binod Dhakal, Joseph Gera +3 more

DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma

Bone Marrow Transplantation(2022)10.1038/s41409-022-01887-0
N/A
0DataRank · unranked
2 citations

Ruta Brazauskas, Bi Qing Teng, Grant Yun, Hannah Uttley, Jing Dong +8 more

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101214
N/A
0DataRank · unranked
17 citations

Fumou Sun, Daisy Alapat, Visanu Wanchai, David E. Mery, Wancheng Guo +24 more

A gene signature can predict risk of MGUS progressing to multiple myeloma

Journal of Hematology & Oncology(2023)10.1186/s13045-023-01472-y
N/A
0DataRank · unranked
14 citations

Yan Cheng, Jun Ying, David E. Mery, Samer Al Hadidi, Visanu Wanchai +16 more

Data from Anaplastic, Plasmablastic, and Plasmacytic Plasmacytomas of Mice: Relationships to Human Plasma Cell Neoplasms and Late-Stage Differentiation of Normal B Cells

(2023)10.1158/0008-5472.c.6495266.v1
Top 100%
0DataRank
Top 100%0 citations

Jeff X. Zhou, Chang Hoon Lee, Zohreh Naghashfar, Shao Xiang, Alexander L. Kovalchuk +7 more

Genetic predisposition to multiple myeloma

Blood and Genomics(2020)10.46701/bg.2020012020103
N/A
0DataRank · unranked
2 citations

Fumou Sun, Xing Cui, Siegfried Janz, Yan Cheng

Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance

Leukemia(2023)10.1038/s41375-023-02078-6
N/A
0DataRank · unranked
0 citations

Shahram Arsang‐Jang, Ben Massat, Bicky Thapa, Victoria Patek, Anita D’Souza +7 more

Orphan nuclear receptor NR2E3 and its small-molecule agonist induce cancer cell apoptosis through regulating p53, IFNα and MYC pathways

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.26.573366
N/A
0DataRank · unranked
0 citations

Todd G. Kroll, Linhui Hao, Ansul Sharma, Vivian Zhou, Luke F. Moat +12 more

Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing

Blood Cancer Journal(2024)10.1038/s41408-024-01024-8
N/A
0DataRank · unranked
7 citations

Shahram Arsang‐Jang, Yan Cheng, Fumou Sun, Anita D’Souza, Binod Dhakal +11 more

Inhibition of FOXM1 synergizes with BCL2 inhibitor Venetoclax in killing non-t(11;14) multiple myeloma cells via repressing MYC pathway

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.27.613548
N/A
0DataRank · unranked
0 citations

Siegfried Janz, Yidan Wang, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Sung Hoon Kim +2 more

Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway

Advanced Science(2025)10.1002/advs.202508822
N/A
0DataRank · unranked
3 citations

Yidan Wang, Kathryn Fox, Adam Bissonnette, Luke F. Moat, Terrie Kitchner +12 more

Data from Anaplastic, Plasmablastic, and Plasmacytic Plasmacytomas of Mice: Relationships to Human Plasma Cell Neoplasms and Late-Stage Differentiation of Normal B Cells

(2023)10.1158/0008-5472.c.6495266
Top 100%
0DataRank
Top 100%0 citations

Jeff X. Zhou, Chang Hoon Lee, Zohreh Naghashfar, Shao Xiang, Alexander L. Kovalchuk +7 more